| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/20/2003 | US6566079 Methods for analyzing protein binding events |
| 05/20/2003 | US6566078 36P6D5: secreted tumor antigen |
| 05/20/2003 | US6566075 Methods for detecting human platelet-derived growth factor receptor agonists and antagonists |
| 05/20/2003 | US6566072 Diagnosing mammary gland cancer in humans; obtain tissue sample, recover proteins, incubate with antibody, detect presence bound antibody, amplified presence of boubd antibody indicates cancer |
| 05/20/2003 | US6566071 Useful as fluorescent labeling reagents |
| 05/20/2003 | US6566069 Gene sequencer and method for determining the nucleotide sequence of a chromosome |
| 05/20/2003 | US6566068 Process for detecting a nucleic acid of interest using an oligo- or polynucleotide probe and intercalators |
| 05/20/2003 | US6566066 Aquaporin-8 variant |
| 05/20/2003 | US6566065 Diagnosing schizophrenia in humans; obtain sample, analyze the methylenetetrahydrofolate reductase nucleic acid expression in sample, genotype sample, presence of mutation indicates schizophrenia |
| 05/20/2003 | US6566064 Diagnosing osteoporosis; obtain tissue sample, genotype, compare to control, evaluate for osteoporosis |
| 05/20/2003 | US6566063 Diagnosing cancer in cells; obtain cells, monitor expression of gland-specific transcription factor, compare to control, evaluate for cancer |
| 05/20/2003 | US6566062 Method for identifying a nucleic acid |
| 05/20/2003 | US6566061 Diagnosing glandular disorders and psychological disorders; obtain tissue sample, detect polymorphism, evaluate for glandular and psychological disorders |
| 05/20/2003 | US6566059 Detecting variability in a nucleotide sequence; obtain nucleotide sequences, replace nucleic acids, cleave sequences, analyze sequences and detect variance in genotypes |
| 05/20/2003 | US6566058 Assay involving looped nucleic acid |
| 05/20/2003 | US6566057 Methods and compositions for peptide libraries displayed on light-emitting scaffolds |
| 05/20/2003 | US6566055 Mass spectrometric analysis of target nucleic acids in sample; obtain nucleotide sequences, incubate with primers, amplify, decrease length and determine mass |
| 05/20/2003 | US6566054 Cyclin dependent kinase mutants, and diagnostic and therapeutic uses related thereto |
| 05/20/2003 | US6566053 Diagnosing tumors in humans; obtain sample, extract nucleotide sequences, incubate with probe, detect hybridization to microsatellite sequences, presence of microsattelite sequences indicates cancer |
| 05/20/2003 | US6566052 Efficient algorithm for PCR testing of blood samples |
| 05/20/2003 | US6566050 Screening agglomerations for clones containing preferential enzymatic polypeptides; obtain sample of agglomeration, culture, incubate with probes, hybridize probe, detect signal, recover clone associated with signal |
| 05/20/2003 | US6566048 Acetyl-COA-carboxylase from Candida albicans |
| 05/20/2003 | US6565857 Coding human leukocyte antigen; anticancer, antitumor agent |
| 05/20/2003 | US6565856 Polypeptide; inducting immunology response |
| 05/20/2003 | US6565855 Polypeptides; genetic engineering |
| 05/20/2003 | US6565848 Cadherin-like asymmetry protein-1, and methods for its use |
| 05/20/2003 | US6565815 Container with window; polymerase chain reaction |
| 05/20/2003 | US6565738 Analyzing of liver disease; measuring alanine aminotransferase |
| 05/20/2003 | CA2412207A1 Stabilized tetrazolium reagent compositions and methods for using the same |
| 05/20/2003 | CA2412198A1 Stabilized tetrazolium-phenazine reagent compositions and methods for using the same |
| 05/20/2003 | CA2199515C Automated molecular biological diagnostic system |
| 05/16/2003 | CA2407575A1 Oligonucleotide-immobilized substrate for detecting methylation |
| 05/15/2003 | WO2003040726A2 Screening for hepatitis c virus entry inhibitors |
| 05/15/2003 | WO2003040694A2 Enzymatic cycling assays for homocysteine and cystathionine |
| 05/15/2003 | WO2003040689A2 Compositions, methods and kits for determining the presence of mycoplasma pneumoniae and/or mycoplasma genitalium in a test sample |
| 05/15/2003 | WO2003040687A2 Isolation and purification of nucleic acids |
| 05/15/2003 | WO2003040684A2 Screening for antiviral affecting signal peptidase |
| 05/15/2003 | WO2003040680A2 Fluorescence-quenching used to detect nucleic acid oligomer hybridization events at high salt concentrations |
| 05/15/2003 | WO2003040670A2 Method of identifying energy transfer sensors for analytes |
| 05/15/2003 | WO2003040415A1 Hiv-1 vpr interactions with mitochondrial apoptosis inducing factor and methods of using the same |
| 05/15/2003 | WO2003040414A1 Method and device for detecting and monitoring alcoholism and related diseases using microarrays |
| 05/15/2003 | WO2003040413A1 System for detecting biological materials in a sample |
| 05/15/2003 | WO2003040411A1 Methods, systems, and kits for analysis of polynucleotides |
| 05/15/2003 | WO2003040410A1 Detection of hybridization oligonucleotide microarray through covalently labeling microarray probe |
| 05/15/2003 | WO2003040409A1 Novel germinal center kinase proteins, compositions, and methods of use |
| 05/15/2003 | WO2003040408A2 Detection of predisposition to osteoporosis |
| 05/15/2003 | WO2003040407A2 Novel markers for cardiopathies |
| 05/15/2003 | WO2003040406A2 Diagnosis of clinical infection of a wound |
| 05/15/2003 | WO2003040405A1 Method for generating idiosyncratic catalytic fingerprint of a sample, processing of said print and systems therefor |
| 05/15/2003 | WO2003040404A1 Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
| 05/15/2003 | WO2003040403A1 Functional assay for genes involved in xylogenesis |
| 05/15/2003 | WO2003040401A2 General screening method for ligand-protein interactions |
| 05/15/2003 | WO2003040400A2 Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids |
| 05/15/2003 | WO2003040397A2 Asymmetric pcr with nuclease-free polymerase or nuclease-resistant molecular beacons |
| 05/15/2003 | WO2003040395A2 Universal nucleotides for nucleic acid analysis |
| 05/15/2003 | WO2003040391A2 Method for producing and identifying soluble protein domains |
| 05/15/2003 | WO2003040390A2 Protease assay for therapeutic drug monitoring |
| 05/15/2003 | WO2003040388A2 Method for detecting bacteria associated with parodontitis and tooth decay |
| 05/15/2003 | WO2003040386A2 Reaction chambers containing complex stable reagent formulations and test kit for detection and isolation of pathogenic microbial nucleic acids |
| 05/15/2003 | WO2003040385A2 Membrane protein interaction assays |
| 05/15/2003 | WO2003040377A1 Method fro selecting genetically transformed cells |
| 05/15/2003 | WO2003040367A1 Method of forming self-assembly by oligonucleotide synthesized by gene amplification reaction and method of detecting self-assembly and gene |
| 05/15/2003 | WO2003040361A1 Stereostructure of dna recombination repair enzyme and utilization thereof |
| 05/15/2003 | WO2003040360A1 Methods of storing and/or delivering an oligomer and/or polymer applied on a support, and supports thereof |
| 05/15/2003 | WO2003040347A2 Baalc expression as a diagnostic marker for acute leukemia |
| 05/15/2003 | WO2003040345A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 05/15/2003 | WO2003040344A2 Transcription factor stress-related polypeptides and methods of use in plants |
| 05/15/2003 | WO2003040340A2 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
| 05/15/2003 | WO2003040334A2 Methods for the identification of inhibitors of 4-coumarate-coa ligase expression or activity in plants |
| 05/15/2003 | WO2003040333A2 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 05/15/2003 | WO2003040331A2 Prostate cancer genes |
| 05/15/2003 | WO2003040329A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 05/15/2003 | WO2003040322A2 Promoters for regulation of gene expression in plant roots |
| 05/15/2003 | WO2003040317A2 Lung cancer therapeutics and diagnostics |
| 05/15/2003 | WO2003040303A2 Functional assay for agonist activation of receptors |
| 05/15/2003 | WO2003040296A2 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 05/15/2003 | WO2003040295A2 Ion channel |
| 05/15/2003 | WO2003040294A2 METHOD FOR THE IN VITRO SYNTHESIS OF SHORT DOUBLE STRANDED RNAs |
| 05/15/2003 | WO2003040285A1 A medium composition, method and device for selectively enhancing the isolation of anaerobic microorganisms contained in a mixed sample with facultative microorganisms |
| 05/15/2003 | WO2003040183A2 Compounds for the diagnosis/prevention/treatment of alzheimer's disease |
| 05/15/2003 | WO2003040177A2 Nucleic acid derived from an alpv virus, compositions containing said nucleic acid and uses thereof |
| 05/15/2003 | WO2003040168A2 Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype |
| 05/15/2003 | WO2003040136A1 Dimeric compounds and their use as anti-viral agents |
| 05/15/2003 | WO2003040100A1 Compositions, methods and kits pertaining to luminescent compounds |
| 05/15/2003 | WO2003040024A2 Assay based on doped nanoparticles |
| 05/15/2003 | WO2003039703A2 Method in the form of a dry rapid test for detecting nucleic acids |
| 05/15/2003 | WO2003039574A1 Endophilin homologous proteins involved in the regulation of energy homeostasis |
| 05/15/2003 | WO2003039490A2 Compositions and methods for diagnosing and treating mental disorders |
| 05/15/2003 | WO2003039484A2 Novel compositions and methods for cancer |
| 05/15/2003 | WO2003039476A2 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874 |
| 05/15/2003 | WO2003039475A2 Methods of identifying and using modulators of fractalkine receptor |
| 05/15/2003 | WO2003039462A2 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 05/15/2003 | WO2003039443A2 Novel genetic markers for leukemias |
| 05/15/2003 | WO2003039404A2 Methods for treating ocular neovascular diseases |
| 05/15/2003 | WO2003039342A2 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145 |
| 05/15/2003 | WO2003039341A2 Methods and compositions to treat cardiovascular disease using 139, 258, 1261, 1486, 2398, 2414, 7660, 8587, 10183, 10550, 12680, 17921, 32248, 60489 or 93804 |
| 05/15/2003 | WO2003039327A2 Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof |
| 05/15/2003 | WO2003039234A2 Pharmacogenomics-based system for clinical applications |
| 05/15/2003 | WO2003002976A3 Methods and reagents for detecting endotoxin |
| 05/15/2003 | WO2003001976A3 A secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby |